New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2013
19:17 EDTVRA, DELL, TTMI, PCRX, CBK, CRS, FIVEOn The Fly: After Hours Movers
UP AFTER EARNINGS/GUIDANCE: Vera Bradley (VRA), up 9.7% after raising its Q4, FY12 EPS views... Christopher & Banks (CBK), up 8.4% after raising its Q4 SSS view... TTM Technologies (TTMI), up 6.8% after providing Q4 EPS and revenue guidance within range of Street... DOWN AFTER EARNINGS/GUIDANCE: Five Below (FIVE), down 1.8% despite raising its Q4 guidance... Pacira Pharmaceuticals (PCRX), down 4.6% after providing Q4, FY12 revenue guidance... Carpenter Technology (CRS), down 6% after providing Q2 EPS, revenue guidance below Street estimates... ALSO LOWER: Dell (DELL), down 1.2% after CNBC's David Faber reported a buyout deal for the company would likely be worth $13.50-$14 per share.
News For VRA;CBK;TTMI;FIVE;PCRX;DELL;CRS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 28, 2015
09:24 EDTPCRXJefferies sees Pharma M&A continuing, lists 22 possible targets
Jefferies analyst David Steinberg believes the M&A wave in the Pharmaceuticals space that began in 2005 can continue as the key drivers remain largely intact. In a note titled "Who is Next? The Feeding Frenzy in Specialty Pharmaceuticals," Steinberg sees deals continuing amid cheap debt, the push for lower corporate taxes and investors rewarding many acquirers for their transactions. He points out there are now around 100 publicly traded Specialty Pharmaceutical companies following the recent life sciences IPO boom. Potential takeover targets, according to Steinberg, include Valeant (VRX), Shire (SHPG), Perrigo (PRGO), Zoetis (ZTS), Mallinckrodt (MNK), Jazz Pharmaceuticals (JAZZ), United Therapeutics (UTHR), Pacira (PCRX), Indivior, Insys Therapeutics (INSY), The Medicines Co. (MDCO), Depomed (DEPO), Spectrum (SPPI), KYTHERA (KYTH), Revance (RVNC), XenoPort (XNPT), Mylan (MYL), Akorn (AKRX), Impax (IPXL), Amphastar Pharmaceuticals (AMPH), Anacor (ANAC) and BioDelivery Sciences (BDSI).
06:33 EDTPCRXPacira completes End-of-Review Exparel snDA process with FDA
Subscribe for More Information
May 21, 2015
06:33 EDTFIVEFive Below initiated with a Market Perform at FBR Capital
Subscribe for More Information
May 20, 2015
09:14 EDTTTMITTM Technologies' Viasystems acquisition cleared by FTC
The investigation of TTM Technologies' (TTMI) proposed acquisition of Viasystems (VIAS) by the Federal Trade Commission has been closed and the parties are free to complete the transaction. TTM intends to close the transaction on or about May 31.
May 19, 2015
16:33 EDTPCRXPacira announces new Exparel data
Subscribe for More Information
May 18, 2015
20:16 EDTFIVEUrban Outfitters down over 16% after disappointing Q1 results
Urban Oufitters (URBN) is down sharply after reporting first quarter earnings per share and revenue that missed analyst estimates. WHAT'S NEW: Urban Oufitters reported Q1 EPS of 25c on revenue of $739.01M, below consensus expectations of 30c and $758.25M, respectively. Urban Outfitters also reported Q1 comparable retail segment net sales up 4%, with Q1 retail segment net sales increasing 17% at Free People, 5% at Urban Outfitters, and 1% at the Anthropologie Group. Wholesale segment net sales rose 18%. WHAT'S NOTABLE: On its Q1 earnings conference call, Urban Outfitters announced that Urban Outfitters Group CEO Ted Marlow, who oversaw the direction of the namesake brand, would retire at the end of August. While Urban Outfitters did not provide guidance, Urban Outfitters Anthropologie Group CEO David McCreight commented on the Anthropologie brand, "We're expecting we could see Q2 shaping up like Q1 in terms of low single-digit comps. We could also see being in the low-mid-single digit comps. It's hard to tell at this point." ANALYST REACTION: Two analyst firms lowered their respective price targets on Urban Outfitters following the company's earnings report. Sterne Agee, which rates Urban Outfitters a Neutral, lowered its 12-month price target to $34 from $46, noting the company has had trouble getting both its Urban Outfitters and Anthropologie brands to perform at the same time. Cantor, which maintained its Buy rating, lowered its price target to $53 from $54, saying that Anthropologie sales disappointed, but noting that a "later catalog release appears to us to have pushed some sales at Anthropologie into May." PRICE ACTION: Urban Outfitters fell 16.4% to just over $34 in after-hours trading. PEERS: Other publicly traded companies in the space include Abercrombie & Fitch (ANF), American Eagle (AEO), Five Below (FIVE), Pacific Sunwear (PSUN), and Zumiez (ZUMZ).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use